Core Viewpoint - The company reported a revenue of $83.55 million for the six months ending June 30, 2025, reflecting a year-on-year increase of 5.88% and a profit attributable to shareholders of $19.785 million, up 5.08% year-on-year, with a proposed special dividend of HK$0.15 (approximately $0.0192) per share [1] Group 1 - The company achieved strong year-on-year growth in the U.S. market despite tariff disruptions, indicating robust demand for its quality products [1] - Emerging markets, particularly in the Asia-Pacific and Europe, Middle East, and Africa regions, have become the main growth engines for the first half of the year due to ongoing socio-economic development [1] - The growth was partially offset by a decrease in sales in the Japanese market and a decline in average selling prices in the Chinese market [1] Group 2 - The increase in net profit was primarily driven by foreign exchange gains and reduced income tax expenses, although it was offset by decreased interest income and increased selling and marketing expenses [1]

Core Viewpoint - Yiju Medical (06929) reported a revenue of $83.55 million for the six months ending June 30, 2025, representing a year-on-year increase of 5.88% [1] - The profit attributable to shareholders for the period was $19.785 million, an increase of 5.08% year-on-year, with basic earnings per share at 2.4 cents [1] - The company proposed a special dividend of 15 Hong Kong cents (approximately 1.92 US cents) per share [1] Group Performance - Despite tariff disruptions, the company achieved strong year-on-year growth in the U.S. market, indicating robust demand for its quality products [1] - Emerging markets, particularly in the Asia-Pacific region and Europe, the Middle East, and Africa, have shown positive trends, becoming the main growth engines in the first half of the year [1] - However, the growth was partially offset by a decrease in sales in the Japanese market and a decline in average selling prices in the Chinese market [1] Financial Analysis - The net profit growth was primarily driven by an increase in foreign exchange gains and a reduction in income tax expenses [1] - This growth was partially countered by a decrease in interest income and an increase in sales and marketing expenses [1]